tums and tirzepatide Tirzepatide for Weight Loss: Physician-Guided
Description
A 2025 observational cohort study published in JAMA Psychiatry tracked 1,847 adults with comorbid obesity and ADHD who initiated GLP-1 receptor agonist therapy for weight management
Tyler et al
Some researchers use an uneven split where the larger dose comes at the beginning of the week
Clinical trials have shown HbA1c reductions of up to 2.4% and body weight losses of up to 22.5%, with improvements in insulin sensitivity, lipid metabolism, and cardiometabolic markers 2,3
If you are switching between medications , recalculate your calorie needs based on your current weight rather than carrying over targets from your previous protocol
